. Author manuscript; available in PMC: 2016 Jul 1.

Published in final edited form as: Psychoneuroendocrinology. 2015 Mar 24;57:1–13. doi: 10.1016/j.psyneuen.2015.03.016

Table 2.

Previously implicated PTSD genes which are differentially expressed in the white non-Hispanic male discovery cohort of n=143 cases and 28 controls. (P_cor<.05).^*,^**

Gene	IlluminaID	t	p	p_cor^***
BDNF	ILMN_1761910	−3.25	0.0014	0.010
NR3C1	ILMN_1668525	−3.31	0.0012	0.010
TXNRD1	ILMN_2324421	2.83	0.0053	0.025

No probes were significant for RORA, COMT, ADCYAP1, ADCYAP1R1, NPSR1, STAT5B, IL16, or S1PR1.

^**

The following genes did not have probes which passed quality checks or were not expressed at sufficient levels to be included in the analysis: TLL1, AC068718.1, FKBP5, NPY, DBH, DRD2, DAT1, SLC6A4, 5-HTR2A, GABRA2, RGS2, MAN2C1, IL18, CASP2, SOD1, and TET1.

^***

Here, p_cor represents correction for 14 probes targeting previously implicated PTSD genes.